Agile Therapeutics Inc. logo

Agile Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Drug Manufacturers - Specialty & Generic

0.62
 
USD
  
0.05
  
(8.99%)
Optionable: Yes  Market Cap: 17 M  90-day average vol: 10,503,369

Previous close: 0.5659  Open: 0.5731  Bid: 0.6249  Ask: 0.6249
52 week range    
0.49   
   50.40
Peers   
TXMD / 
ATRS / 
JNJ / 
MRK / 
Last updated: Friday 5th August 2022
39
MarketXLS Rank marketxls
60
Value marketxls
23
Technical marketxls
34
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ATRS

1 B8.93.51

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

PFE

0.0302298 B15.153.21

TXMD

0 B-0.60.2679
Chart
News
Agile Therapeutics: Worst Is Over
Seeking Alpha 11/13/2021
46 Biggest Movers From Yesterday
Yahoo Finance 10/19/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 11.061


Financials

AGRX Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues000000007490004 M
Cost of sales-23662-12000-12000-18000-19000-23000-23000-16300060008 M
Gross operating profit00000000467000-7 M
Selling Gen & administrative expense6 M4 M5 M7 M9 M12 M9 M9 M36 M58 M
Research & development expense17 M9 M13 M26 M21 M14 M10 M10 M14 M6 M
Operating income-23 M-13 M-19 M-33 M-30 M-27 M-19 M-19 M-49 M-71 M
floaterest income0000000000
floaterest expense0000000000
Other income net171013-81000348000-1 M234000143000-990000000
Pre-tax Income (EBT)-23 M-14 M-20 M-36 M-32 M-28 M-20 M-19 M-52 M-75 M
Income taxes00-4 M-6 M-3 M0-477000000
Net income from total operations-23 M-14 M-16 M-30 M-29 M-28 M-20 M-19 M-52 M-75 M
Minority floaterest0000000000
Total net income-23 M-14 M-16 M-30 M-29 M-28 M-20 M-19 M-52 M-75 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-23 M-14 M-16 M-30 M-29 M-28 M-20 M-19 M-52 M-75 M
Depreciation236621200012000180001900023000230001630002760002 M
Amortization0000000000
Operating income before depreciation (EBITDA)-23 M-13 M-18 M-34 M-29 M-26 M-19 M-18 M-48 M-69 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-2.58-1.59-1.41-1.38-1.02-0.91-0.58-0.38-24.4-30.8
Diluted EPS total-2.58-1.59-1.41-1.38-1.02-0.91-0.58-0.38-24.4-30.8
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!